[
  {
    "ts": "2026-02-27T14:34:00+00:00",
    "headline": "Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway",
    "summary": "KYMR posts wider-than-expected Q4 loss as R&D jumps and collaboration revenues fall, but $1.6B cash haul and KT-621 progress bolster pipeline outlook.",
    "url": "https://finance.yahoo.com/news/kymera-q4-loss-wider-expected-143400001.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "3fb1c7a2-f16d-3ff8-9589-ccb451b547e1",
      "content": {
        "id": "3fb1c7a2-f16d-3ff8-9589-ccb451b547e1",
        "contentType": "STORY",
        "title": "Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway",
        "description": "",
        "summary": "KYMR posts wider-than-expected Q4 loss as R&D jumps and collaboration revenues fall, but $1.6B cash haul and KT-621 progress bolster pipeline outlook.",
        "pubDate": "2026-02-27T14:34:00Z",
        "displayTime": "2026-02-27T14:34:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/57.Lfvcoa8N_9pHFAUTShA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/39hBnd4FwGlouiqapgQKxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/kymera-q4-loss-wider-expected-143400001.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/kymera-q4-loss-wider-expected-143400001.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KYMR"
            },
            {
              "symbol": "CSTL"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-27T13:58:01+00:00",
    "headline": "Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector?",
    "summary": "As Gilead Sciences has outperformed its sector peers recently, analysts remain highly optimistic about the stock’s prospects.",
    "url": "https://www.barchart.com/story/news/468446/gilead-sciences-stock-is-gild-outperforming-the-healthcare-sector",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "2f4f12c9-c5be-3452-8195-c9749a78f1fc",
      "content": {
        "id": "2f4f12c9-c5be-3452-8195-c9749a78f1fc",
        "contentType": "STORY",
        "title": "Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector?",
        "description": "",
        "summary": "As Gilead Sciences has outperformed its sector peers recently, analysts remain highly optimistic about the stock’s prospects.",
        "pubDate": "2026-02-27T13:58:01Z",
        "displayTime": "2026-02-27T13:58:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/31e98582ac8bd44916a76a1228c3e08e",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Gilead Sciences, Inc_ logo and vials -by Melnikov Dmitriy via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4ZVwOdK61Xg8o5Mr50Lzcw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/31e98582ac8bd44916a76a1228c3e08e.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mZU7yS6z0JfGzyXqezjBuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/31e98582ac8bd44916a76a1228c3e08e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/468446/gilead-sciences-stock-is-gild-outperforming-the-healthcare-sector",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-stock-gild-outperforming-135801608.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]